Science & Medicine
MHRA Chief Executive: Today’s Learning Will Inform Next Gen Products
Dr. Ian Hudson serves as Chief Executive for the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom, and is Program Co-Chair of DIA’s EuroMeeting 2017 in Glasgow, Scotland. In this exclusive podcast, Dr. Hudson explains his views on the global “access versus evidence” debate, regulatory supports (and hurdles) to innovation, and the timeliness of the EuroMeeting theme, From Bench to Bedside – and Back. “This theme clearly emphasizes the life cycle approach that both companies and regulators take,” he explains. “It’s all the way through, from the bench to the bedside, getting products to the patients; and then, once products are being used extensively in the marketplace for the benefit of public health, key learnings from that can be taken back in to perhaps the next generation of products.” Register for DIA EuroMeeting 2017 in Glasgow!
It is Free